Bavarian Nordic A/S Key Executives

This section highlights Bavarian Nordic A/S's key executives, including their titles and compensation details.

Unlock Executive Information

Upgrade to access executive details

Upgrade Now

Find Contacts at Bavarian Nordic A/S

(Showing 0 of )

Unlock Team Information

Upgrade to access team member details

Upgrade Now

Bavarian Nordic A/S Earnings

This section highlights Bavarian Nordic A/S's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.

Next Earnings Date

Date: May 09, 2025
Time: Before Market
Est. EPS: $-
Status: Unconfirmed

Last Earnings Results

Date: March 05, 2025
EPS: $9.84
Est. EPS: $8.20
Revenue: $2.09B

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-03-05 $8.20 $9.84
Read Transcript Q3 2024 2024-11-15 $0.78 $0.36
Read Transcript Q2 2024 2024-08-22 $1.90 $3.34
Read Transcript Q1 2024 2024-05-11 N/A N/A
Read Transcript Q4 2023 2024-03-06 $7.80 $11.70
Read Transcript Q3 2023 2023-11-16 $6.43 $-4.40
Read Transcript Q2 2023 2023-08-23 $3.95 $7.10
Read Transcript Q1 2023 2023-05-14 N/A N/A

Bavarian Nordic A/S (BAVA.CO)

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.

Healthcare Biotechnology

$163.05

Stock Price

$12.81B

Market Cap

-

Employees

Hellerup, None

Location

Financial Statements

Access annual & quarterly financial statements for Bavarian Nordic A/S, including income statements, balance sheets, and cash flow statements..

Annual Income Statement

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Revenue $5.72B $7.06B $3.15B $1.90B $1.85B
Cost of Revenue $2.90B $2.54B $1.45B $1.33B $1.20B
Gross Profit $2.82B $4.53B $1.70B $570.32M $657.29M
Gross Profit Ratio 49.31% 64.10% 53.99% 30.10% 35.48%
Research and Development Expenses $862.51M $2.23B $1.18B $399.16M $341.42M
General and Administrative Expenses $516.14M $540.85M $376.02M $292.92M $278.14M
Selling and Marketing Expenses $500.34M $331.58M $212.93M $191.78M $285.78M
Selling General and Administrative Expenses $1.02B $815.78M $588.96M $484.70M $563.93M
Other Expenses $939.77M $- $- $- $-627.65M
Operating Expenses $2.82B $3.02B $1.77B $883.86M $277.70M
Cost and Expenses $5.72B $5.56B $3.22B $2.21B $1.47B
Interest Income $48.31M $40.21M $26.00K $1.74M $193.00K
Interest Expense $77.87M $105.52M $119.69M $152.06M $177.00M
Depreciation and Amortization $624.90M $553.82M $399.25M $387.69M $344.08M
EBITDA $1.67B $2.05B $84.28M $35.80M $657.91M
EBITDA Ratio 29.29% 29.05% 12.55% 6.59% 43.72%
Operating Income $- $1.50B $-3.85M $-263.31M $449.62M
Operating Income Ratio 0.00% 21.20% -0.12% -13.87% 24.27%
Total Other Income Expenses Net $971.36M $-14.58M $-260.83M $-140.88M $-97.61M
Income Before Tax $971.36M $1.48B $-331.61M $-454.43M $281.98M
Income Before Tax Ratio 16.99% 21.00% -10.52% -23.94% 15.22%
Income Tax Expense $-16.62M $7.75M $15.77M $10.35M $4.46M
Net Income $987.98M $1.48B $-347.38M $-464.77M $277.52M
Net Income Ratio 17.28% 20.89% -11.03% -24.49% 14.98%
EPS $12.61 $19.23 $-4.93 $-7.37 $5.13
EPS Diluted $12.61 $19.23 $-4.93 $-7.37 $5.13
Weighted Average Shares Outstanding 78.32M 76.71M 70.42M 63.10M 54.05M
Weighted Average Shares Outstanding Diluted 78.32M 76.71M 70.42M 63.10M 54.05M
SEC Filing Source Source Source Source Source


Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Revenue $2.09B $1.36B $1.43B $831.47M $2.45B $1.38B $1.99B $1.25B $1.29B $1.00B $536.70M $320.06M $543.97M $448.66M $370.00M $535.25M $228.91M $558.49M $699.58M $365.40M
Cost of Revenue $839.90M $783.76M $707.55M $566.24M $832.80M $514.37M $683.73M $428.40M $342.28M $383.75M $431.31M $292.18M $387.00M $313.91M $249.30M $377.34M $326.93M $245.60M $379.49M $243.08M
Gross Profit $1.25B $579.60M $719.95M $265.24M $1.62B $862.03M $1.30B $823.66M $948.19M $619.81M $105.39M $27.87M $156.96M $134.74M $120.70M $157.91M $-98.01M $312.89M $320.09M $122.32M
Gross Profit Ratio 59.89% 42.50% 50.40% 31.90% 66.00% 62.60% 65.60% 65.80% 73.50% 61.80% 19.60% 8.70% 28.90% 30.00% 32.60% 29.50% -42.82% 56.02% 45.75% 33.48%
Research and Development Expenses $203.54M $264.28M $209.59M $185.11M $446.26M $980.17M $503.63M $298.02M $533.31M $360.12M $184.86M $104.80M $105.43M $74.51M $97.08M $122.14M $115.06M $102.30M $57.98M $66.08M
General and Administrative Expenses $154.14M $117.60M $124.08M $120.33M $158.60M $111.31M $180.69M $90.25M $126.53M $81.48M $90.23M $77.79M $67.35M $69.64M $83.20M $72.73M $77.74M $74.08M $74.88M $51.45M
Selling and Marketing Expenses $187.09M $104.15M $120.39M $88.69M $96.97M $96.61M $72.37M $65.63M $77.37M $50.24M $47.93M $37.39M $56.11M $37.58M $47.06M $51.03M $63.34M $72.58M $75.02M $74.85M
Selling General and Administrative Expenses $341.24M $221.75M $244.47M $209.02M $255.57M $207.92M $253.06M $155.88M $203.90M $131.72M $138.15M $115.17M $123.46M $107.22M $130.26M $123.77M $141.08M $146.65M $149.90M $126.30M
Other Expenses $709.20M $93.57M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-627.65M
Operating Expenses $1.25B $579.60M $454.06M $394.13M $701.83M $1.19B $756.69M $453.90M $737.21M $491.85M $323.02M $219.97M $228.89M $181.73M $227.34M $245.91M $256.14M $248.95M $207.88M $-435.27M
Cost and Expenses $2.09B $1.36B $1.16B $960.37M $1.53B $1.70B $1.44B $882.30M $1.08B $875.60M $754.33M $512.16M $615.90M $495.64M $476.64M $623.25M $583.07M $494.55M $587.36M $-192.18M
Interest Income $12.59M $9.36M $9.55M $16.81M $17.36M $10.35M $11.91M $3.31M $4.23M $6.41M $827.00K $149.00K $399.00K $1.24M $56.00K $41.00K $- $- $5.00K $188.00K
Interest Expense $11.24M $23.48M $21.39M $21.76M $5.96M $2.04M $22.15M $30.22M $104.08M $7.14M $17.70M $32.75M $41.83M $33.46M $43.98M $32.79M $59.96M $1.69M $35.76M $39.65M
Depreciation and Amortization $163.63M $156.89M $153.65M $150.73M $149.89M $148.73M $143.46M $111.74M $103.13M $98.41M $99.31M $98.40M $102.48M $98.56M $97.39M $89.26M $92.61M $98.72M $85.20M $83.62M
EBITDA $921.91M $252.84M $441.03M $21.84M $1.05B $-183.75M $686.91M $494.46M $259.67M $226.37M $-118.32M $-167.71M $9.75M $24.34M $-9.25M $1.26M $-275.50M $162.66M $197.41M $641.20M
EBITDA Ratio 44.03% 18.54% 30.90% 2.63% 43.47% 27.53% 35.24% 38.87% 27.10% 22.68% -12.16% -23.34% 9.44% 14.04% 0.67% 1.53% -100.75% 28.88% 31.61% 177.44%
Operating Income $- $93.57M $265.89M $-128.90M $914.83M $-331.09M $560.21M $374.94M $246.57M $129.25M $-164.59M $-173.09M $-51.75M $-35.55M $-94.93M $-81.08M $-323.24M $62.57M $135.93M $564.74M
Operating Income Ratio 0.00% 6.86% 18.63% -15.50% 37.35% -24.06% 28.20% 29.95% 19.11% 12.88% -30.67% -54.08% -9.51% -7.92% -25.66% -15.15% -141.21% 11.20% 19.43% 154.55%
Total Other Income Expenses Net $747.05M $-21.11M $97.00K $14.75M $-16.52M $-3.42M $-3.55M $6.72M $-55.46M $-108.62M $-18.23M $-78.52M $-25.82M $-31.83M $-41.49M $-41.74M $-18.33M $-13.76M $-223.00K $-42.00M
Income Before Tax $747.05M $72.46M $265.99M $-114.14M $898.32M $-334.51M $542.66M $376.48M $155.52M $19.34M $-235.86M $-270.62M $-97.75M $-78.82M $-148.13M $-129.73M $-372.48M $26.88M $111.99M $515.59M
Income Before Tax Ratio 35.68% 5.31% 18.63% -13.73% 36.67% -24.30% 27.32% 30.07% 12.05% 1.93% -43.95% -84.55% -17.97% -17.57% -40.04% -24.24% -162.72% 4.81% 16.01% 141.10%
Income Tax Expense $-23.76M $1.97M $4.86M $310.00K $-3.07M $6.14M $4.58M $113.00K $5.90M $7.24M $1.31M $1.32M $4.48M $2.62M $2.12M $1.11M $2.20M $532.00K $715.00K $1.01M
Net Income $770.81M $70.49M $261.13M $-114.45M $901.39M $-340.65M $538.08M $376.37M $149.62M $12.11M $-237.17M $-271.94M $-102.23M $-81.44M $-150.26M $-130.84M $-374.68M $26.35M $111.28M $514.58M
Net Income Ratio 36.81% 5.17% 18.29% -13.76% 36.80% -24.75% 27.09% 30.06% 11.59% 1.21% -44.19% -84.97% -18.79% -18.15% -40.61% -24.45% -163.68% 4.72% 15.91% 140.82%
EPS $9.84 $0.90 $3.30 $-1.47 $11.75 $-4.37 $6.90 $4.83 $2.12 $0.20 $-3.40 $-3.90 $-1.63 $-1.30 $-2.40 $-2.20 $-7.11 $0.50 $2.20 $12.60
EPS Diluted $9.84 $0.90 $3.34 $-1.47 $11.75 $-4.37 $6.90 $4.83 $2.12 $0.20 $-3.40 $-3.90 $-1.63 $-1.30 $-2.40 $-2.20 $-7.11 $0.50 $2.20 $12.60
Weighted Average Shares Outstanding 78.32M 78.32M 79.13M 78.10M 76.71M 77.93M 77.93M 77.87M 70.55M 60.54M 69.76M 69.73M 62.65M 62.65M 62.61M 59.47M 52.70M 52.70M 50.58M 40.84M
Weighted Average Shares Outstanding Diluted 78.32M 78.32M 78.12M 78.10M 76.71M 77.93M 77.93M 77.87M 70.55M 60.54M 69.76M 69.73M 62.65M 62.65M 62.61M 59.48M 52.70M 52.70M 50.58M 40.84M
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents $1.62B $1.48B $575.41M $591.82M $285.49M
Short Term Investments $551.54M $390.25M $2.27B $3.12B $1.38B
Cash and Short Term Investments $2.18B $1.87B $2.85B $3.72B $1.67B
Net Receivables $- $1.78B $523.14M $381.62M $139.29M
Inventory $2.33B $1.64B $919.07M $480.04M $521.08M
Other Current Assets $1.28B $113.73M $197.20M $175.36M $50.24M
Total Current Assets $5.79B $5.40B $4.48B $4.75B $2.38B
Property Plant Equipment Net $2.24B $2.45B $1.75B $1.49B $1.08B
Goodwill $- $- $- $- $-
Intangible Assets $6.33B $6.48B $5.94B $5.80B $5.29B
Goodwill and Intangible Assets $6.33B $6.48B $5.94B $5.80B $5.29B
Long Term Investments $- $11.19M $5.09M $4.78M $4.12M
Tax Assets $- $-11.19M $-5.09M $-4.78M $-4.12M
Other Non-Current Assets $45.51M $4.56M $212.62M $43.16M $-6.37B
Total Non-Current Assets $8.62B $8.95B $7.91B $7.34B $6.38B
Other Assets $- $- $- $- $-
Total Assets $14.41B $14.35B $12.39B $12.09B $8.76B
Account Payables $1.05B $954.14M $605.93M $263.61M $345.32M
Short Term Debt $41.54M $46.55M $1.14B $896.34M $24.01M
Tax Payables $- $7.21M $16.55M $3.74M $497.00K
Deferred Revenue $- $7.21M $- $725.39M $579.54M
Other Current Liabilities $1.71B $1.78B $526.49M $779.54M $508.14M
Total Current Liabilities $2.80B $2.79B $2.29B $1.91B $952.31M
Long Term Debt $86.71M $98.76M $629.26M $236.95M $447.47M
Deferred Revenue Non-Current $- $1 $2.32B $2.57B $2.46B
Deferred Tax Liabilities Non-Current $- $29.07M $-2.89B $-2.73B $-2.46B
Other Non-Current Liabilities $113.59M $1.10B $2.32B $2.57B $2.46B
Total Non-Current Liabilities $200.29M $1.23B $2.95B $2.81B $2.91B
Other Liabilities $- $- $- $- $-
Total Liabilities $3.00B $4.01B $5.24B $4.71B $3.86B
Preferred Stock $- $- $- $- $-
Common Stock $788.55M $780.98M $707.35M $704.68M $584.50M
Retained Earnings $10.43B $9.33B $6.30B $6.59B $4.25B
Accumulated Other Comprehensive Income Loss $- $230.49M $143.52M $82.19M $64.57M
Other Total Stockholders Equity $185.82M $-1.54M $-1.46M $-1.11M $-1.08M
Total Stockholders Equity $11.41B $10.34B $7.15B $7.37B $4.89B
Total Equity $11.41B $10.34B $7.15B $7.37B $4.89B
Total Liabilities and Stockholders Equity $14.41B $14.35B $12.39B $12.09B $8.76B
Minority Interest $- $- $- $- $-
Total Liabilities and Total Equity $14.41B $14.35B $12.39B $12.09B $8.76B
Total Investments $551.54M $401.43M $2.27B $3.12B $1.38B
Total Debt $128.25M $145.30M $1.76B $1.13B $470.06M
Net Debt $-1.50B $-1.33B $1.18B $540.77M $184.58M


Balance Sheet Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Cash and Cash Equivalents $1.62B $996.69M $816.40M $860.81M $1.48B $1.03B $831.80M $1.27B $575.41M $718.65M $290.80M $401.37M $591.82M $341.82M $185.90M $245.84M $285.49M $561.45M $376.92M $1.46B
Short Term Investments $551.54M $874.80M $1.42B $1.43B $390.25M $474.06M $553.10M $1.70B $2.27B $2.52B $2.96B $3.05B $3.12B $2.30B $2.33B $2.34B $1.38B $2.01B $2.00B $740.63M
Cash and Short Term Investments $2.18B $1.87B $2.24B $2.29B $1.87B $1.51B $1.38B $2.97B $2.85B $3.24B $3.25B $3.45B $3.72B $2.64B $2.51B $2.59B $1.67B $2.57B $2.38B $2.21B
Net Receivables $- $- $- $663.09M $1.78B $1.16B $1.31B $783.65M $523.14M $654.28M $506.89M $285.40M $381.62M $302.97M $339.95M $159.19M $139.29M $130.66M $318.29M $210.60M
Inventory $2.33B $2.18B $1.99B $1.78B $1.64B $1.74B $1.51B $1.20B $919.07M $591.21M $518.41M $603.57M $480.04M $553.28M $667.44M $552.83M $521.08M $357.46M $154.60M $186.76M
Other Current Assets $1.28B $1.13B $54.66M $78.86M $113.73M $52.69M $211.54M $165.24M $197.20M $58.69M $79.01M $103.39M $175.36M $99.64M $61.14M $42.26M $50.24M $33.99M $34.93M $28.07M
Total Current Assets $5.79B $5.19B $5.39B $4.82B $5.40B $4.46B $4.42B $5.12B $4.48B $4.55B $4.36B $4.44B $4.75B $3.59B $3.58B $3.34B $2.38B $3.09B $2.89B $2.63B
Property Plant Equipment Net $2.24B $2.31B $2.35B $2.38B $2.45B $2.38B $2.42B $1.75B $1.75B $1.71B $1.69B $1.62B $1.49B $1.34B $1.23B $1.17B $1.08B $991.71M $977.75M $946.66M
Goodwill $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Intangible Assets $6.33B $6.42B $6.51B $6.40B $6.48B $6.54B $7.90B $6.08B $5.94B $5.86B $5.81B $5.88B $5.80B $5.16B $5.19B $5.23B $5.29B $5.36B $5.37B $5.42B
Goodwill and Intangible Assets $6.33B $6.42B $6.51B $6.40B $6.48B $6.54B $7.90B $6.08B $5.94B $5.86B $5.81B $5.88B $5.80B $5.16B $5.19B $5.23B $5.29B $5.36B $5.37B $5.42B
Long Term Investments $- $- $9.45M $10.04M $11.19M $12.18M $12.16M $9.04M $5.09M $5.31M $4.97M $4.84M $4.78M $4.69M $4.68M $4.56M $- $- $- $-
Tax Assets $- $- $-9.45M $- $- $1.75M $1.72M $-9.04M $-5.09M $-5.31M $-4.97M $-4.84M $-4.78M $-4.69M $-4.68M $-4.56M $- $- $- $-
Other Non-Current Assets $45.51M $28.35M $13.31M $12.09M $4.56M $7.33M $236.37M $228.46M $212.62M $170.10M $169.72M $52.31M $43.16M $19.46M $4.68M $4.56M $4.12M $4.13M $3.96M $3.62M
Total Non-Current Assets $8.62B $8.76B $8.88B $8.80B $8.95B $8.94B $10.58B $8.06B $7.91B $7.75B $7.67B $7.55B $7.34B $6.52B $6.43B $6.41B $6.38B $6.36B $6.35B $6.37B
Other Assets $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Assets $14.41B $13.95B $14.27B $13.62B $14.35B $13.40B $14.99B $13.18B $12.39B $12.29B $12.03B $11.99B $12.09B $10.12B $10.01B $9.75B $8.76B $9.45B $9.24B $9.01B
Account Payables $1.05B $672.78M $1.12B $480.27M $954.14M $793.69M $764.23M $444.83M $605.93M $381.90M $195.46M $204.42M $263.61M $222.79M $298.55M $273.29M $345.32M $296.17M $201.50M $150.91M
Short Term Debt $41.54M $37.65M $41.89M $46.93M $46.55M $39.55M $45.97M $25.76M $1.14B $898.37M $898.10M $897.29M $896.34M $852.69M $330.87M $24.11M $24.01M $22.86M $17.49M $16.04M
Tax Payables $- $6.69M $6.93M $4.32M $7.21M $7.61M $7.47M $3.94M $16.55M $6.66M $4.48M $3.98M $3.74M $2.06M $1.46M $1.13M $497.00K $258.00K $- $-
Deferred Revenue $- $- $35.00K $4.32M $7.21M $2.05B $2.11B $- $- $19.33M $118.22M $120.42M $725.39M $1.19B $1.17B $1.12B $579.54M $1.45B $512.80M $541.42M
Other Current Liabilities $1.71B $2.36B $2.48B $2.40B $1.77B $2.05B $2.11B $1.31B $526.49M $1.01B $979.87M $805.16M $779.54M $1.18B $1.15B $1.08B $508.14M $1.38B $490.09M $514.94M
Total Current Liabilities $2.80B $3.08B $3.65B $2.94B $2.79B $2.89B $2.93B $1.79B $2.29B $2.31B $2.20B $2.03B $1.91B $2.31B $1.83B $1.45B $952.31M $1.78B $735.55M $710.00M
Long Term Debt $86.71M $76.65M $82.73M $86.67M $98.76M $66.54M $882.16M $707.36M $629.26M $631.42M $552.78M $75.73M $236.95M $80.57M $457.38M $462.21M $447.47M $454.09M $466.15M $469.13M
Deferred Revenue Non-Current $- $- $- $72.00M $1.02B $1.03B $1.42B $1.56B $2.32B $2.39B $2.40B $2.52B $2.57B $1.95B $1.93B $1.92B $2.46B $1.95B $2.79B $2.72B
Deferred Tax Liabilities Non-Current $- $28.53M $27.96M $27.58M $29.07M $27.79M $27.42M $- $-2.89B $-2.96B $-2.88B $- $-2.73B $-1.95B $-1.93B $-1.92B $-2.46B $-1.95B $-2.79B $-2.72B
Other Non-Current Liabilities $113.59M $79.23M $77.64M $397.16M $1.10B $56.38M $55.62M $1.56B $2.32B $2.39B $2.40B $2.76B $2.57B $- $1.93B $- $2.46B $1.95B $2.79B $2.72B
Total Non-Current Liabilities $200.29M $184.41M $188.33M $511.41M $1.23B $1.18B $2.38B $2.27B $2.95B $3.02B $2.95B $2.83B $2.81B $2.03B $2.39B $2.38B $2.91B $2.41B $3.26B $3.18B
Other Liabilities $- $- $1 $1 $1 $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities $3.00B $3.26B $3.84B $3.45B $4.01B $4.06B $5.31B $4.06B $5.24B $5.34B $5.15B $4.87B $4.71B $4.35B $4.22B $3.83B $3.86B $4.19B $3.99B $3.89B
Preferred Stock $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock $788.55M $788.33M $781.16M $780.98M $780.98M $779.29M $779.29M $778.73M $707.35M $706.94M $704.79M $704.73M $704.68M $640.65M $638.17M $637.37M $584.50M $584.50M $584.50M $583.00M
Retained Earnings $10.43B $9.67B $9.46B $9.22B $9.33B $8.43B $8.77B $8.23B $6.30B $6.13B $6.08B $6.32B $6.59B $5.07B $5.09B $5.22B $4.25B $4.59B $4.58B $4.44B
Accumulated Other Comprehensive Income Loss $- $- $197.26M $173.81M $230.49M $131.80M $141.04M $117.74M $143.52M $120.37M $93.06M $97.88M $82.19M $61.59M $65.17M $60.26M $64.57M $93.22M $91.06M $83.28M
Other Total Stockholders Equity $185.82M $224.40M $-2.84M $-1.29M $-1.54M $-1.54M $-1.54M $-1.30M $-1.46M $-1.46M $-1.46M $-871.00K $-1.11M $-1.18M $-1.18M $-946.00K $-1.08M $-1.08M $-553.00K $-599.00K
Total Stockholders Equity $11.41B $10.69B $10.44B $10.17B $10.34B $9.34B $9.69B $9.12B $7.15B $6.96B $6.88B $7.13B $7.37B $5.77B $5.79B $5.92B $4.89B $5.26B $5.25B $5.11B
Total Equity $11.41B $10.69B $10.44B $10.17B $10.34B $9.34B $9.69B $9.12B $7.15B $6.96B $6.88B $7.13B $7.37B $5.77B $5.79B $5.92B $4.89B $5.26B $5.25B $5.11B
Total Liabilities and Stockholders Equity $14.41B $13.95B $14.27B $13.62B $14.35B $13.40B $14.99B $13.18B $12.39B $12.29B $12.03B $11.99B $12.09B $10.12B $10.01B $9.75B $8.76B $9.45B $9.24B $9.01B
Minority Interest $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities and Total Equity $14.41B $13.95B $14.27B $13.62B $14.35B $13.40B $14.99B $13.18B $12.39B $12.29B $12.03B $11.99B $12.09B $10.12B $10.01B $9.75B $8.76B $9.45B $9.24B $9.01B
Total Investments $551.54M $874.80M $1.43B $1.44B $401.43M $474.06M $553.10M $1.70B $2.27B $2.52B $2.96B $3.05B $3.12B $2.30B $2.33B $2.34B $1.38B $2.01B $2.00B $740.63M
Total Debt $128.25M $114.30M $124.61M $133.59M $145.30M $106.09M $928.13M $733.12M $1.76B $1.53B $1.45B $973.03M $1.13B $932.42M $787.34M $485.27M $470.06M $476.94M $482.15M $485.18M
Net Debt $-1.50B $-882.39M $-691.79M $-727.22M $-1.33B $-926.09M $96.33M $-538.60M $1.18B $811.14M $1.16B $571.66M $540.77M $590.60M $601.44M $239.43M $184.58M $-84.50M $105.23M $-979.35M

Annual Cash Flow

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Net Income $987.98M $1.48B $-347.38M $-464.77M $277.52M
Depreciation and Amortization $624.90M $553.82M $399.25M $388.31M $360.15M
Deferred Income Tax $- $- $- $-10.41M $-33.68M
Stock Based Compensation $78.67M $55.48M $49.28M $56.86M $33.00M
Change in Working Capital $176.91M $-1.55B $-148.79M $-469.36M $-162.69M
Accounts Receivables $617.86M $-1.35B $-133.17M $-364.39M $-88.09M
Inventory $-683.57M $-599.01M $-439.03M $41.04M $-420.32M
Accounts Payables $- $368.74M $423.41M $-146.01M $345.72M
Other Working Capital $242.62M $24.74M $423.41M $-146.01M $345.72M
Other Non Cash Items $81.37M $585.68M $267.69M $140.88M $97.61M
Net Cash Provided by Operating Activities $1.95B $1.12B $220.05M $-358.50M $571.91M
Investments in Property Plant and Equipment $-82.66M $-977.40M $-1.38B $-1.06B $-706.71M
Acquisitions Net $- $-1.83B $1.02B $575.32M $501.88M
Purchases of Investments $-1.48B $-49.54M $-584.07M $-2.15B $-2.35B
Sales Maturities of Investments $1.29B $1.91B $1.09B $336.34M $1.14B
Other Investing Activities $-1.60B $- $-1.02B $-575.32M $-501.88M
Net Cash Used for Investing Activities $-1.87B $-945.56M $-877.40M $-2.88B $-1.91B
Debt Repayment $-1.92M $-865.54M $629.32M $657.83M $-1.39B
Common Stock Issued $126.79M $1.69B $37.92M $2.96B $2.84B
Common Stock Repurchased $-27.46M $-8.99M $-9.33M $-8.58M $-11.10M
Dividends Paid $- $- $- $- $-
Other Financing Activities $-41.64M $-77.06M $-22.09M $-76.94M $-103.18M
Net Cash Used Provided by Financing Activities $55.77M $735.83M $635.82M $3.54B $1.33B
Effect of Forex Changes on Cash $11.51M $-7.65M $5.12M $5.70M $-7.31M
Net Change in Cash $146.26M $901.83M $-16.41M $306.33M $-12.06M
Cash at End of Period $1.62B $1.48B $575.41M $591.82M $285.49M
Cash at Beginning of Period $1.48B $575.41M $591.82M $285.49M $297.55M
Operating Cash Flow $1.95B $1.12B $220.05M $-358.50M $571.91M
Capital Expenditure $-1.69B $-977.40M $-1.38B $-1.06B $-706.71M
Free Cash Flow $262.19M $141.80M $-1.16B $-1.42B $-134.80M

Cash Flow Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Net Income $770.81M $70.49M $261.13M $-114.45M $901.39M $-340.65M $538.08M $376.37M $149.62M $12.11M $-237.17M $-271.94M $-102.23M $-81.44M $-150.26M $-130.84M $-374.68M $26.35M $111.28M $514.58M
Depreciation and Amortization $163.63M $156.89M $153.65M $150.73M $149.89M $710.00M $139.88M $111.74M $103.13M $98.41M $99.31M $98.40M $103.10M $98.56M $97.39M $89.26M $92.61M $98.72M $85.20M $83.62M
Deferred Income Tax $- $- $- $- $-843.58M $15.56M $-3.24M $- $- $- $- $- $-14.17M $9.60M $1.18M $-7.02M $-10.57M $-11.15M $-4.17M $-7.79M
Stock Based Compensation $17.39M $14.35M $23.29M $23.64M $14.08M $9.80M $14.99M $16.60M $15.86M $7.92M $18.87M $6.64M $1.48M $20.99M $8.15M $26.24M $8.73M $7.38M $10.53M $6.36M
Change in Working Capital $-21.55M $-320.60M $165.23M $353.83M $-505.37M $-97.18M $-250.78M $-697.63M $-101.62M $-99.79M $-55.18M $107.80M $-125.37M $50.60M $-255.69M $-138.90M $-150.15M $157.00M $37.20M $-206.74M
Accounts Receivables $-121.64M $33.20M $-415.55M $1.12B $-653.72M $88.50M $-514.09M $-266.12M $20.52M $-134.44M $-188.37M $169.12M $-150.51M $-3.96M $-199.51M $-10.41M $-29.66M $187.64M $-107.41M $-138.66M
Inventory $-142.73M $-191.87M $-209.83M $-139.15M $92.34M $-231.54M $-174.51M $-285.30M $-327.86M $-72.81M $85.16M $-123.53M $73.23M $114.17M $-114.61M $-31.75M $-163.62M $-202.87M $32.17M $-86.00M
Accounts Payables $- $- $789.57M $-624.74M $31.65M $45.11M $438.20M $-146.21M $205.71M $107.45M $48.03M $62.21M $-48.10M $-59.60M $58.44M $-96.74M $- $- $- $-
Other Working Capital $242.81M $-161.94M $1.04M $-4.13M $24.36M $758.00K $-371.00K $-146.21M $205.71M $107.45M $48.03M $231.33M $-198.61M $-63.57M $-141.07M $-107.15M $13.47M $359.87M $5.03M $-120.74M
Other Non Cash Items $25.10M $7.24M $27.56M $-11.38M $869.04M $8.45M $3.55M $-21.78M $50.47M $103.75M $30.58M $82.89M $25.82M $31.83M $41.49M $41.74M $18.33M $37.06M $223.00K $42.00M
Net Cash Provided by Operating Activities $955.37M $-71.63M $630.87M $435.23M $585.45M $305.97M $442.48M $-214.69M $217.45M $122.39M $-143.59M $23.80M $-111.38M $130.15M $-257.73M $-119.53M $-415.73M $315.36M $240.25M $432.03M
Investments in Property Plant and Equipment $-30.93M $-1.84M $-651.26M $-6.68M $-244.14M $-173.13M $-317.27M $-242.86M $-807.04M $-175.37M $-96.97M $-302.18M $-665.27M $-180.13M $-117.35M $-95.69M $-484.94M $-103.51M $-62.98M $-55.29M
Acquisitions Net $- $- $- $11.53M $3.88M $142.88M $164.90M $-361.92M $- $- $- $- $489.31M $44.38M $27.12M $14.51M $388.47M $61.41M $19.50M $32.50M
Purchases of Investments $-418.01M $-5.59M $875.00K $-1.06B $1.86M $-4.78M $-19.94M $-26.67M $-76.67M $-13.39M $-467.65M $-26.36M $-1.00B $-36.42M $-54.97M $-1.06B $-171.31M $-68.59M $-1.43B $-673.37M
Sales Maturities of Investments $723.43M $554.60M $11.33M $5.63M $94.69M $77.65M $1.14B $600.43M $300.69M $385.50M $368.02M $34.03M $145.16M $40.17M $62.24M $88.78M $795.99M $65.78M $181.40M $98.51M
Other Investing Activities $-599.90M $-397.02M $-11.53M $-1.05B $-218.72M $-142.88M $-2.00B $361.92M $-3.60M $1.00K $-1.00K $3.60M $-489.31M $-44.38M $-27.12M $-14.51M $-388.47M $-61.41M $-19.50M $-32.50M
Net Cash Used for Investing Activities $-325.42M $150.15M $-650.59M $-1.05B $-143.72M $-100.27M $-1.03B $330.89M $-586.62M $196.73M $-196.60M $-290.91M $-1.52B $-176.38M $-110.09M $-1.07B $139.74M $-106.32M $-1.31B $-630.14M
Debt Repayment $-490.00K $-484.00K $-1.78M $-471.00K $-469.00K $-462.00K $159.52M $-1.02B $230.94M $79.47M $239.46M $79.45M $203.04M $149.17M $306.16M $-544.00K $8.40M $-541.00K $-5.35M $-1.39B
Common Stock Issued $3.21M $120.85M $2.74M $- $24.06M $- $8.07M $1.66B $5.83M $30.54M $900.00K $645.00K $1.71B $56.00M $16.55M $1.18B $- $- $-4.27M $2.85B
Common Stock Repurchased $- $- $-27.46M $- $- $- $-8.99M $- $- $- $-9.33M $- $- $- $-8.58M $- $- $-11.10M $- $-
Dividends Paid $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Financing Activities $-19.64M $-10.44M $- $-10.26M $-10.37M $-11.09M $-8.68M $-46.92M $-5.92M $24.84M $-5.76M $-4.71M $-36.75M $51.12M $-5.28M $-30.03M $-4.68M $-9.20M $-5.70M $2.75B
Net Cash Used Provided by Financing Activities $-16.92M $109.92M $-26.49M $-10.73M $13.21M $-11.55M $149.92M $584.25M $230.85M $104.31M $225.26M $75.39M $1.88B $200.29M $308.86M $1.15B $3.72M $-20.84M $-11.05M $1.36B
Effect of Forex Changes on Cash $13.77M $-8.14M $1.80M $4.08M $-9.89M $6.22M $158.00K $-4.13M $-4.92M $4.41M $4.36M $1.27M $1.63M $1.87M $-974.00K $3.17M $-3.69M $-3.68M $-2.00M $2.06M
Net Change in Cash $626.80M $180.29M $-44.41M $-616.42M $445.05M $200.38M $-439.92M $696.31M $-143.24M $427.85M $-110.56M $-190.45M $250.00M $155.92M $-59.93M $-39.65M $-275.96M $184.52M $-1.09B $1.17B
Cash at End of Period $1.62B $996.69M $816.40M $860.81M $1.48B $1.03B $831.80M $1.27B $575.41M $718.65M $290.80M $401.37M $591.82M $341.82M $185.90M $245.84M $285.49M $561.45M $376.92M $1.46B
Cash at Beginning of Period $996.69M $816.40M $860.81M $1.48B $1.03B $831.80M $1.27B $575.41M $718.65M $290.80M $401.37M $591.82M $341.82M $185.90M $245.84M $285.49M $561.45M $376.92M $1.46B $297.55M
Operating Cash Flow $955.37M $-71.63M $630.87M $435.23M $585.45M $305.97M $442.48M $-214.69M $217.45M $122.39M $-143.59M $23.80M $-111.38M $130.15M $-257.73M $-119.53M $-415.73M $315.36M $240.25M $432.03M
Capital Expenditure $-630.84M $-398.86M $-651.26M $-6.68M $-244.14M $-173.13M $-317.27M $-242.86M $-807.04M $-175.37M $-96.97M $-302.18M $-665.27M $-180.13M $-117.35M $-95.69M $-484.94M $-103.51M $-62.98M $-55.29M
Free Cash Flow $324.53M $-470.49M $-20.40M $428.55M $341.30M $132.84M $125.22M $-457.56M $-589.60M $-52.98M $-240.56M $-278.39M $-776.66M $-49.98M $-375.08M $-215.22M $-900.67M $211.85M $177.28M $376.74M

Bavarian Nordic A/S Dividends

Explore Bavarian Nordic A/S's dividend history, including dividend yield, payout ratio, and historical payments.

Bavarian Nordic A/S does not currently pay a dividend.

Bavarian Nordic A/S News

Read the latest news about Bavarian Nordic A/S, including recent articles, headlines, and updates.

Similar Companies

A
Ambu A/S

AMBU-B.CO

Price: $121.95

Market Cap: $32.87B

D
Danske Bank A/S

DANSKE.CO

Price: $230.70

Market Cap: $192.36B

D
DSV A/S

DSV.CO

Price: $1445.00

Market Cap: $339.50B

F
FLSmidth & Co. A/S

FLS.CO

Price: $360.80

Market Cap: $20.51B

G
Genmab A/S

GMAB.CO

Price: $1363.50

Market Cap: $86.65B

Related Metrics

Explore detailed financial metrics and analysis for BAVA.CO.